The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Open accessAbstract
The isolation and analysis of circulating cell‐free tumor DNA in plasma is a powerful tool with considerable potential to improve clinical outcomes across multiple cancer types, including NSCLC. Assays of this nature that use blood as opposed to tumor samples are frequently referred to as liquid biopsies. An increasing number of innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen. Circulating tumor DNA assays for detection of both EGFR sensitizing and resistance mutations have already entered clinical practice and many other molecular tests — such as detection of resistance mutations for Anaplastic Lymphoma Kinase (ALK) receptor tyrosine kinase rearrangements — are likely to do so in the near future. Due to an abundance of new evidence, an appraisal was warranted to review strengths and weaknesses, to describe what is already in clinical practice and what has yet to be implemented, and to highlight areas in need of further investigation. A multidisciplinary panel of experts in the field of thoracic oncology with interest and expertise in liquid biopsy and molecular pathology was convened by the International Association for the Study of Lung Cancer to evaluate current available evidence with the aim of producing a set of recommendations for the use of liquid biopsy for molecular analysis in guiding the clinical management of advanced NSCLC patients as well as identifying unmet needs. In summary, the panel concluded that liquid biopsy approaches have significant potential to improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings relevant to NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261 · cited 1×
“The phase III randomized clinical trials for gefitinib (IPASS) and afatinib (LUX-Lung 3) examined EGFR mutational status in tumor DNA extracted from standard tissue biopsy specimens as well ctDNA extracted from serum liquid biopsy specimens.(1,32) Overall, the sensitivity level reached in these studies using a real-ti…”
Self-citationRosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Self-citationRittmeyer, A., Barlesi, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Dols, M. C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,675
Self-citationOsimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
Self-citationSequist, L. V., Yang, J. C.-H., Yamamoto, N., O'Byrne, K., Hirsh, V., Mok, T., Geater, S. L., Orlov, S., Tsai, C.-M., Boyer, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2806 · Cited by 3,228
Self-citationCirculating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Jänne, P. A., Yang, J. C.-H., Kim, D.-W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M.-J., Kim, S.-W., Su, W.-C., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411817 · Cited by 2,116
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak-Jones, C. L., Wolff, D. J., Younes, A., et al. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.10.002 · Cited by 2,030
Wu, Y.-L., Zhou, C., Hu, C.-P., Feng, J., Lu, S., Huang, Y., Li, W., Hou, M., Shi, J. H., Lee, K. Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70604-1 · Cited by 1,978
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Huang, A. C., Postow, M. A., Orlowski, R. J., Mick, R., Bengsch, B., Manne, S., Xu, W., Harmon, S., Giles, J. R., Wenz, B., et al. (2017) · Nature · doi:10.1038/nature22079 · Cited by 1,664
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3854 · Cited by 1,589 · cited 1×
“7,73,74 As fi rst-line use of osimertinib gains popularity with the results of the FLAURA trial, the frequency of T790M will decline, but understanding mechanisms of resistance to osimertinib will likely be of clinical utility to patients in the near future.”
Absolute quantification by droplet digital PCR versus analog real-time PCR
Hindson, C. M., Chevillet, J. R., Briggs, H. A., Gallichotte, E. N., Ruf, I. K., Hindson, B. J., Vessella, R. L., & Tewari, M. (2013) · Nature Methods · doi:10.1038/nmeth.2633 · Cited by 1,488
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M., & Shendure, J. (2016) · Cell · doi:10.1016/j.cell.2015.11.050 · Cited by 1,464
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
Gainor, J. F., Shaw, A. T., Sequist, L. V., Fu, X., Azzoli, C. G., Piotrowska, Z., Huynh, T. G., Zhao, L., Fulton, L., Schultz, K. R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3101 · Cited by 1,250
Self-citationGainor, J. F., Dardaei, L., Yoda, S., Friboulet, L., Leshchiner, I., Katayama, R., Dagogo-Jack, I., Gadgeel, S., Schultz, K., Singh, M., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0596 · Cited by 1,148
Self-citationIntegrated digital error suppression for improved detection of circulating tumor DNA
Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., Stehr, H., Liu, C. L., Bratman, S. V., Say, C., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3520 · Cited by 1,099
Self-citationChaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,072
Self-citationDetection of ultra-rare mutations by next-generation sequencing
Schmitt, M. W., Kennedy, S. R., Salk, J. J., Fox, E. J., Hiatt, J. B., & Loeb, L. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208715109 · Cited by 1,047
Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 930
Self-citationBest, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Anagnostou, V., Smith, K. N., Forde, P. M., Niknafs, N., Bhattacharya, R., White, J., Zhang, T., Adleff, V., Phallen, J., Wali, N., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0828 · Cited by 896
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Jia, Y., Yun, C.-H., Park, E., Ercan, D., Manuia, M., Juarez, J., Xu, C., Rhee, K., Chen, T., Zhang, H., et al. (2016) · Nature · doi:10.1038/nature17960 · Cited by 886
Oxnard, G. R., Thress, K. S., Alden, R. S., Lawrance, R., Paweletz, C. P., Cantarini, M., Yang, J. C.-H., Barrett, J. C., & Jänne, P. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7162 · Cited by 850
Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer-a meta-analysis
Lee, C. K., Man, J., Lord, S., Links, M., Gebski, V., Mok, T., & Yang, J. C.-H. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.007 · Cited by 839
Self-citationGros, A., Parkhurst, M. R., Tran, E., Pasetto, A., Robbins, P. F., Ilyas, S., Prickett, T. D., Gartner, J. J., Crystal, J. S., Roberts, I. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4051 · Cited by 829
Complication rates of CT-guided transthoracic lung biopsy: meta-analysis
Heerink, W. J., de Bock, G. H., de Jonge, G. J., Groen, H. J. M., Vliegenthart, R., & Oudkerk, M. (2017) · European Radiology · doi:10.1007/s00330-016-4357-8 · Cited by 746
Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695 · cited 3×
“57,58 This, in turn, leads to greater sensitivity (in this context: detection of low frequency variants) by increasing con fi dence in calls made from extremely limited counts.”
Reck, M., Popat, S., Reinmuth, N., De Ruysscher, D., Kerr, K. M., & Peters, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu199 · Cited by 679
Self-citationChabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., Kurtz, D. M., Stehr, H., Scherer, F., Karlovich, C. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11815 · Cited by 648
Self-citationGoss, G., Tsai, C.-M., Shepherd, F. A., Bazhenova, L., Lee, J. S., Chang, G.-C., Crino, L., Satouchi, M., Chu, Q., Hida, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30508-3 · Cited by 645
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
Self-citationSacher, A. G., Paweletz, C., Dahlberg, S. E., Alden, R. S., O’Connell, A., Feeney, N., Mach, S. L., Jänne, P. A., & Oxnard, G. R. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0173 · Cited by 571
Yang, J. C.-H., Ahn, M.-J., Kim, D.-W., Ramalingam, S. S., Sequist, L. V., Su, W.-C., Kim, S.-W., Kim, J.-H., Planchard, D., Felip, E., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3223 · Cited by 571
Self-citationNivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
Gettinger, S., Rizvi, N. A., Chow, L. Q., Borghaei, H., Brahmer, J., Ready, N., Gerber, D. E., Shepherd, F. A., Antonia, S., Goldman, J. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9929 · Cited by 501
Self-citationBEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Diehl, F., Li, M., He, Y., Kinzler, K. W., Vogelstein, B., & Dressman, D. (2006) · Nature Methods · doi:10.1038/nmeth898 · Cited by 496
Thress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Mok, T., Wu, Y.-L., Lee, J. S., Yu, C.-J., Sriuranpong, V., Sandoval-Tan, J., Ladrera, G., Thongprasert, S., Srimuninnimit, V., Liao, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2594 · Cited by 468
Self-citationCombination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
Das, R., Verma, R., Sznol, M., Boddupalli, C. S., Gettinger, S. N., Kluger, H., Callahan, M., Wolchok, J. D., Halaban, R., Dhodapkar, M. V., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401686 · Cited by 461
Piotrowska, Z., Niederst, M. J., Karlovich, C. A., Wakelee, H. A., Neal, J. W., Mino-Kenudson, M., Fulton, L., Hata, A. N., Lockerman, E. L., Kalsy, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0399 · Cited by 458
Self-citationPlanchard, D., Kim, T. M., Mazieres, J., Quoix, E., Riely, G., Barlesi, F., Souquet, P.-J., Smit, E. F., Groen, H. J. M., Kelly, R. J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00077-2 · Cited by 453
Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318299ac32 · Cited by 452
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., McCormack, R., Webster, A., & Milenkova, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.721 · Cited by 412
DNA sequencing technologies: 2006–2016
Mardis, E. R. (2017) · Nature Protocols · doi:10.1038/nprot.2016.182 · Cited by 395
Thompson, J. C., Yee, S. S., Troxel, A. B., Savitch, S. L., Fan, R., Balli, D., Lieberman, D. B., Morrissette, J. D., Evans, T. L., Bauml, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1231 · Cited by 325
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Taniguchi, K., Uchida, J., Nishino, K., Kumagai, T., Okuyama, T., Okami, J., Higashiyama, M., Kodama, K., Imamura, F., & Kato, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1712 · Cited by 315
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311
Salipante, S. J., Kawashima, T., Rosenthal, C., Hoogestraat, D. R., Cummings, L. A., Sengupta, D. J., Harkins, T. T., Cookson, B. T., & Hoffman, N. G. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02206-14 · Cited by 301
Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
Katayama, R., Friboulet, L., Koike, S., Lockerman, E. L., Khan, T. M., Gainor, J. F., Iafrate, A. J., Takeuchi, K., Taiji, M., Okuno, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1511 · Cited by 290
Reckamp, K. L., Melnikova, V. O., Karlovich, C., Sequist, L. V., Camidge, D. R., Wakelee, H., Perol, M., Oxnard, G. R., Kosco, K., Croucher, P., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.035 · Cited by 287
Self-citationNicolazzo, C., Raimondi, C., Mancini, M., Caponnetto, S., Gradilone, A., Gandini, O., Mastromartino, M., del Bene, G., Prete, A., Longo, F., et al. (2016) · Scientific Reports · doi:10.1038/srep31726 · Cited by 281
Jenkins, S., Yang, J. C.-H., Ramalingam, S. S., Yu, K., Patel, S., Weston, S., Hodge, R., Cantarini, M., Jänne, P. A., Mitsudomi, T., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.04.003 · Cited by 269
Paweletz, C. P., Sacher, A. G., Raymond, C. K., Alden, R. S., O'Connell, A., Mach, S. L., Kuang, Y., Gandhi, L., Kirschmeier, P., English, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1627-t · Cited by 244
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Karachaliou, N., Mayo-de las Casas, C., Queralt, C., de Aguirre, I., Melloni, B., Cardenal, F., Garcia-Gomez, R., Massuti, B., Sánchez, J. M., Porta, R., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.257 · Cited by 239
Yang, M., Shen, H., Qiu, C., Ni, Y., Wang, L., Dong, W., Liao, Y., & Du, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.031 · Cited by 226
Zheng, D., Ye, X., Zhang, M. Z., Sun, Y., Wang, J. Y., Ni, J., Zhang, H. P., Zhang, L., Luo, J., Zhang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep20913 · Cited by 226
Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanché, H., Girard, N., Trédaniel, J., Guilleminault, L., Gervais, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3063 · Cited by 215
Kang, Q., Henry, N. L., Paoletti, C., Jiang, H., Vats, P., Chinnaiyan, A. M., Hayes, D. F., Merajver, S. D., Rae, J. M., & Tewari, M. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.03.012 · Cited by 209
Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., Tannous, J., Kuiper, J. L., Drees, E., Grabowska, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6279 · Cited by 202
Khagi, Y., Goodman, A. M., Daniels, G. A., Patel, S. P., Sacco, A. G., Randall, J. M., Bazhenova, L. A., & Kurzrock, R. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1439 · Cited by 202
Lam, N. Y. L., Rainer, T. H., Chiu, R. W. K., & Lo, Y. M. D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026013 · Cited by 196
Meric-Bernstam, F., Brusco, L., Daniels, M., Wathoo, C., Bailey, A. M., Strong, L., Shaw, K., Lu, K., Qi, Y., Zhao, H., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw018 · Cited by 195
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Medina Diaz, I., Nocon, A., Mehnert, D. H., Fredebohm, J., Diehl, F., & Holtrup, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166354 · Cited by 192
Chouaid, C., Dujon, C., Do, P., Monnet, I., Madroszyk, A., Le Caer, H., Auliac, J. B., Berard, H., Thomas, P., Lena, H., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.08.016 · Cited by 187
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
Wei, F., Lin, C.-C., Joon, A., Feng, Z., Troche, G., Lira, M. E., Chia, D., Mao, M., Ho, C.-L., Su, W.-C., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1003oc · Cited by 176
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
Malapelle, U., Sirera, R., Jantus-Lewintre, E., Reclusa, P., Calabuig-Fariñas, S., Blasco, A., Pisapia, P., Rolfo, C., & Camps, C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1288568 · Cited by 171
Self-citationRemon, J., Caramella, C., Jovelet, C., Lacroix, L., Lawson, A., Smalley, S., Howarth, K., Gale, D., Green, E., Plagnol, V., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx017 · Cited by 168
Weber, B., Meldgaard, P., Hager, H., Wu, L., Wei, W., Tsai, J., Khalil, A. A., Nexø, E., & Sørensen, B. S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-294 · Cited by 162
van Dessel, L. F., Beije, N., Helmijr, J. C. A., Vitale, S. R., Kraan, J., Look, M. P., de Wit, R., Sleijfer, S., Jansen, M. P. H. M., Martens, J. W. M., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12037 · Cited by 162
Tumor-Educated Platelets as Liquid Biopsy in Cancer Patients
Joosse, S. A., & Pantel, K. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.007 · Cited by 161
Lee, J. Y., Qing, X., Wei, X., Yali, B., Chi, S., Bak, S. H., Lee, H. Y., Sun, J., Lee, S., Ahn, J. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6874 · Cited by 161
Sherwood, J. L., Corcoran, C., Brown, H. J., Sharpe, A. D., Musilová, M., & Kohlmann, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150197 · Cited by 160
Tang, Y., Cui, Y., Li, Z., Jiao, Z., Zhang, Y., He, Y., Chen, G., Zhou, Q., Wang, W., Zhou, X., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0285-3 · Cited by 152
Schwaederle, M. C., Patel, S. P., Husain, H., Ikeda, M., Lanman, R. B., Banks, K. C., Talasaz, A. H., Bazhenova, L. A., & Kurzrock, R. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2497 · Cited by 147
Husain, H., Melnikova, V. O., Kosco, K. A., Woodward, B. D., More, S., Pingle, S. C., Weihe, E., Park, B. H., Tewari, M., Erlander, M. G., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0454 · Cited by 146
Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
Cai, W., Lin, D., Wu, C., Li, X., Zhao, C., Zheng, L.-M., Chuai, S., Fei, K., Zhou, C., & Hirsch, F. R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8293 · Cited by 137
Self-citationMalapelle, U., de-las-Casas, C. M., Rocco, D., Garzón, M., Pisapia, P., Jordana‐Ariza, N., Russo, M., Sgariglia, R., Luca, C. D., Pepe, F., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.8 · Cited by 137
Guibert, N. M., Hu, Y., Feeney, N. B., Kuang, Y., Plagnol, V., Jones, G. R., Howarth, K., Beeler, J. F., Paweletz, C. P., & Oxnard, G. R. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy005 · Cited by 135
Rosell, R., Wei, J., & Tarón, M. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.001 · Cited by 133
Dagogo‐Jack, I., Brannon, A. R., Ferris, L. A., Campbell, C. D., Lin, J. J., Schultz, K. R., Ackil, J., Stevens, S. E., Dardaei, L., Yoda, S., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00160 · Cited by 133
Self-citationExosomes as diagnostic and predictive biomarkers in lung cancer
Reclusa, P., Taverna, S., Pucci, M., Duréndez-Saéz, E., Fariñas, S. C., Manca, P., Serrano, M. J., Sober, L., Pauwels, P., Russo, A. D., et al. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.67 · Cited by 123
Self-citationJiang, B., Li, Y.-S., Guo, W., Zhang, X., Chen, Z., Su, J., Zhong, W., Yang, X., Yang, J., Shao, Y. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0047 · Cited by 120
Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory
Nikolaev, S. I., Lemmens, L., Koessler, T., Blouin, J., & Nouspikel, T. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.11.004 · Cited by 119
Uchida, J., Kato, K., Kukita, Y., Kumagai, T., Nishino, K., Daga, H., Nagatomo, I., Inoue, T., Kimura, M., Oba, S., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241414 · Cited by 117
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
Vendrell, J. A., Mau‐Them, F. T., Béganton, B., Godreuil, S., Coopman, P. J., & Solassol, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020264 · Cited by 109
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA
Toro, P. V., Avigdor, B. E., Beaver, J. A., Cochran, R. L., VanDenBerg, D. A., Yakim, E., Cravero, K., Chu, D. T. W., Zabransky, D. J., Wong, H. Y., et al. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.07.097 · Cited by 105
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
Malapelle, U., Pisapia, P., Rocco, D., Smeraglio, R., Spirito, M. D., Bellevicine, C., & Troncone, G. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.10.08 · Cited by 105
Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review
Sacher, A. G., Komatsubara, K. M., & Oxnard, G. R. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.05.022 · Cited by 103
Plagnol, V., Woodhouse, S., Howarth, K., Lensing, S. V., Smith, M. J., Epstein, M., Madi, M., Smalley, S., Leroy, C., Hinton, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193802 · Cited by 95
Hu, Y., Alden, R. S., Odegaard, J. I., Fairclough, S. R., Chen, R., Heng, J. C., Feeney, N. B., Nagy, R. J., Shah, J. M., Ulrich, B. C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1745 · Cited by 89
Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer
Ma, J., Lin, Y., Zhan, M., Mann, D. L., Stass, S. A., & Jiang, F. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.88 · Cited by 87
Rolfo, C. D., Giovannetti, E., Hong, D. S., Bivona, T. G., Raez, L. E., Bronte, G., Buffoni, L., Reguart, N., Santos, E. S., Germonpré, P. R., et al. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.05.009 · Cited by 87
Self-citationGandara, D. R., Kowanetz, M., Mok, T. S. K., Rittmeyer, A., Fehrenbacher, L., Fabrizio, D. A., Otto, G. A., Malboeuf, C. M., Lieber, D. S., Paul, S. M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx380 · Cited by 87
Self-citationYuan, D., Xu, J., Wang, J., Pan, Y., Fu, J., Bai, Y., Zhang, J., & Shao, C. (2016) · Oncotarget · doi:10.18632/oncotarget.9017 · Cited by 86
Rozenblum, A. B., Ilouze, M., Dudnik, E., Dvir, A., Soussan‐Gutman, L., Geva, S., & Peled, N. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.021 · Cited by 83
Self-citationRothwell, D. G., Smith, N., Morris, D., Leong, H. S., Li, Y., Hollebecque, A., Ayub, M., Carter, L., Antonello, J., Franklin, L., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.11.006 · Cited by 81
Detection of tumor ALK status in neuroblastoma patients using peripheral blood
Combaret, V., Iacono, I., Bellini, A., Bréjon, S., Bernard, V., Marabelle, A., Coze, C., Pierron, G., Lapouble, E., Schleiermacher, G., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.414 · Cited by 79
Harel, S. A., Moshe, N. B. B., Aylon, Y., Bublik, D. R., Moskovits, N. B.-C., Toperoff, G., Azaiza, D., Biagoni, F., Fuchs, G., Wilder, S., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.221 · Cited by 78
Malapelle, U., Mayo‐de‐las‐Casas, C., Molina‐Vila, M. Á., Rosell, R., Savic, S., Bihl, M., Bubendorf, L., Salto‐Tellez, M., de Biase, D., Tallini, G., et al. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21868 · Cited by 78
Self-citationImplementation and utilization of the molecular tumor board to guide precision medicine
Harada, S., Arend, R. C., Dai, Q., Levesque, J. A., Winokur, T. S., Guo, R., Heslin, M. J., Nabell, L. M., Nabors, B., Limdi, N. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18471 · Cited by 78
The Importance of Careful Blood Processing in Isolation of Cell‐Free DNA
PAGE, K., Powles, T., Slade, M. J., Bella, M. T. D., Walker, R. A., Coombes, R. C., & Shaw, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.042 · Cited by 71
Wu, Y.-L. L. C., Sequist, L. V. D., Tan, E.-H., Geater, S. L., Орлов, С. В., Zhang, L., Lee, K. H., Tsai, C., Kato, T., Barrios, C. H., et al. (2018) · Clinical Lung Cancer · doi:10.1016/j.cllc.2018.03.009 · Cited by 66
Self-citationGiallombardo, M., Chacartegui, J. J., Castiglia, M., Steen, N. V. D., Mertens, I., Pauwels, P., Peeters, M., & Rolfo, C. D. (2016) · Journal of Visualized Experiments · doi:10.3791/53900 · Cited by 60
Self-citationConcordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens
Müller, J. N., Falk, M., Talwar, J., Neemann, N., Mariotti, E., Bertrand, M., Zacherle, T., Lakis, S., Menon, R., Gloeckner, C., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.07.014 · Cited by 58
Bordi, P., Tiseo, M., Rofi, E., Petrini, I., Restante, G., Danesi, R., & Re, M. D. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.013 · Cited by 53
Peled, N., Roisman, L. C., Miron, B., Pfeffer, R., Lanman, R. B., Ilouze, M., Dvir, A., Soussan‐Gutman, L., Barlési, F., Tarcic, G., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.02.023 · Cited by 51
Self-citationThress, K. S., Markovets, A. A., Barrett, J. C., Chmielecki, J., Goldberg, S. B., Shepherd, F. A., Vowler, S. L., & Oxnard, G. R. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.9018 · Cited by 40
Self-citationSabari, J. K., Montecalvo, J., Chen, R., Dienstag, J., Mrad, C., Bergagnini, I., Lai, W.-C. V., Arbour, K. C., Shu, C. A., Hellmann, M. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8512 · Cited by 39
Wakelee, H. A., Gadgeel, S. M., Goldman, J. W., Reckamp, K. L., Karlovich, C., Melnikova, V. O., Soria, J., Yu, H. A., Solomon, B., Pérol, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.9001 · Cited by 32
Self-citationWang, Q., Yang, X., He, Y., Ma, Q., Li, L., Fu, P., & Xiao, H. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.04.002 · Cited by 29
Chai, X., Ren, P., Wei, B., Ma, J., Mai, L., Cram, D. S., Yongping, S., & Guo, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.04.003 · Cited by 28
Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples
Zhao, C., Li, X., Li, J., Zhang, Y., Ren, S., Chen, X., & Zhou, C. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.013 · Cited by 25
Clinical utility of circulating cell-free DNA in advanced colorectal cancer
Pereira, A. A. L., Morelli, M. P., Overman, M. J., Kee, B. K., Fogelman, D. R., Vilar, E., Shureiqi, I., Raghav, K. P. S., Eng, C., Manuel, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183949 · Cited by 25
Wang, Y., Liu, Z., Yin, H., Hu, J., Zhong, S., Chen, W., & Zhao, J. (2017) · Gene · doi:10.1016/j.gene.2017.10.073 · Cited by 12
Cited by
Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C., Mok, T. S., Reck, M., Van Schil, P. E., Hellmann, M. D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy275 · Cited by 2,274
Self-citationTargeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
Tan, A. C., & Tan, D. S. W. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01626 · Cited by 779
Self-citationRolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., Bivona, T., Diehn, M., Dive, C., Dziadziuszko, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.017 · Cited by 683
Self-citationUpdate 2020: Management of Non-Small Cell Lung Cancer
Alexander, M., Kim, S. Y., & Cheng, H. (2020) · Lung · doi:10.1007/s00408-020-00407-5 · Cited by 648
Leighl, N. B., Page, R. D., Raymond, V. M., Daniel, D. B., Divers, S. G., Reckamp, K. L., Villalona-Calero, M. A., Dix, D., Odegaard, J. I., Lanman, R. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0624 · Cited by 587
Metadata
- Authors
- Rolfo, C., Mack, P. C., Scagliotti, G. V., Baas, P., Barlesi, F., Bivona, T. G., Herbst, R. S., Mok, T. S., Peled, N., Pirker, R., Raez, L. E., Reck, M., Riess, J. W., Sequist, L. V., Shepherd, F. A., Sholl, L. M., Tan, D. S. W., Wakelee, H. A., Wistuba, I. I., Wynes, M. W., Carbone, D. P., Hirsch, F. R., & Gandara, D. R.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 13
- Issue
- 9
- Pages
- 1248-1268
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2807519281
- Cited by
- 660
- References
- 118
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.